Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses
暂无分享,去创建一个
D. Barouch | N. Provine | M. Seaman | E. Borducchi | R. Larocca | P. Penaloza-MacMaster | A. Badamchi-Zadeh | Christine A Bricault
[1] A. Brzozowski,et al. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies , 2015, PloS one.
[2] John P. Moore,et al. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity , 2015, Journal of Virology.
[3] H. Schuitemaker,et al. Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys , 2015, Science.
[4] Hongmei Gao,et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. , 2014, Journal of immunological methods.
[5] D. Kaufman,et al. Longitudinal Requirement for CD4+ T Cell Help for Adenovirus Vector–Elicited CD8+ T Cell Responses , 2014, The Journal of Immunology.
[6] D. Bhattacharya,et al. Adjuvant-specific regulation of long-term antibody responses by ZBTB20 , 2014, The Journal of experimental medicine.
[7] P. McKay,et al. Enhanced Immunogenicity of an HIV-1 DNA Vaccine Delivered with Electroporation via Combined Intramuscular and Intradermal Routes , 2014, Journal of Virology.
[8] Jerome H. Kim,et al. Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys , 2013, Cell.
[9] J. Hamid,et al. A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity , 2013, Science Translational Medicine.
[10] S. Targ,et al. T Follicular Helper Cell Dynamics in Germinal Centers , 2013, Science.
[11] D. Barouch,et al. Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors , 2012, Journal of Virology.
[12] T. Strutt,et al. Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.
[13] A. Folgori,et al. Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man , 2012, Science Translational Medicine.
[14] Sang-Jun Ha,et al. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection , 2011, Proceedings of the National Academy of Sciences.
[15] Jerome H. Kim,et al. Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys , 2011, Nature.
[16] Mario Roederer,et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates , 2011, Nature Medicine.
[17] A. Davidoff,et al. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine , 2011, Gene Therapy.
[18] S. Crotty,et al. Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.
[19] Judith Nedrow Production. JOURNAL OF VIROLOGY , 2011, Journal of Virology.
[20] M. Roederer,et al. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform , 2010, The Journal of experimental medicine.
[21] D. Kaufman,et al. Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8+ T Lymphocytes , 2010, Journal of Virology.
[22] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[23] Burton E. Barnett,et al. Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.
[24] D. Montefiori,et al. Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys , 2008, Nature.
[25] T. Nakayama,et al. Development and characterization of IL-21–producing CD4+ T cells , 2008, The Journal of experimental medicine.
[26] K. Mansfield,et al. Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D , 2007, Journal of Virology.
[27] J. Bramson,et al. The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity1 , 2006, The Journal of Immunology.
[28] S. Kostense,et al. Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1 , 2004, The Journal of Immunology.
[29] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[30] J. Cyster,et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position , 2002, Nature.
[31] J. McCluskey,et al. Cognate T Cell Help Is Sufficient to Trigger Anti-Nuclear Autoantibodies in Naive Mice1 , 2001, The Journal of Immunology.
[32] S. Harrison,et al. Expression, Purification, and Characterization of gp160e, the Soluble, Trimeric Ectodomain of the Simian Immunodeficiency Virus Envelope Glycoprotein, gp160* , 2000, The Journal of Biological Chemistry.
[33] Scott R. Presnell,et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.
[34] E. Ingulli,et al. Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.
[35] A. B. Lyons,et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help , 1996, The Journal of experimental medicine.
[36] B Zheng,et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. , 1995, Journal of immunology.
[37] F. Finkelman,et al. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo , 1995, The Journal of experimental medicine.
[38] R. Zinkernagel,et al. T helper cell unresponsiveness: Rapid induction in antigen‐transgenic and reversion in non‐transgenic mice , 1994, European journal of immunology.
[39] R. Zinkernagel,et al. Virus or a hapten‐carrier complex can activate autoreactive B cells by providing linked T help , 1994, European journal of immunology.
[40] M. Cooke,et al. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death , 1993, Cell.
[41] D. Gray,et al. Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.
[42] Jun Zhang,et al. Sites of specific B cell activation in primary and secondary responses to T cell‐dependent and T cell‐independent antigens , 1991, European journal of immunology.
[43] L. Chieco‐Bianchi,et al. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. , 1991, Journal of immunology.
[44] K. Rajewsky,et al. Persistence of memory B cells in mice deprived of T cell help. , 1990, International immunology.
[45] Jeffrey Crosbie,et al. Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.
[46] J. Goronzy,et al. Persistent suppression of virus-specific cytotoxic T cell responses after transient depletion of CD4+ T cells in vivo. , 1989, Journal of Immunology.
[47] D. Nemazee,et al. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.
[48] W. Paul,et al. T help requirements for the generation of an in vivo IgE response: a late acting form of T cell help other than IL-4 is required for IgE but not for IgG1 production. , 1989, Journal of immunology.
[49] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[50] C. Fathman,et al. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 , 1986, The Journal of experimental medicine.
[51] H. Waldmann,et al. Induction of tolerance by monoclonal antibody therapy , 1986, Nature.
[52] Samir Guglani. Death , 1890, The Lancet.
[53] D. Calado,et al. Germinal Centers , 2017, Methods in Molecular Biology.
[54] Yonghong,et al. The CD8 T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity , 2005 .